Loading...
XLON
PRU
Market cap28bUSD
Apr 01, Last price  
833.80GBP
1D
0.92%
1Q
30.89%
Jan 2017
-38.15%
Name

Prudential PLC

Chart & Performance

D1W1MN
XLON:PRU chart
No data to show
P/E
1,654.07
P/S
235.05
EPS
0.65
Div Yield, %
2.52%
Shrs. gr., 5y
1.29%
Rev. gr., 5y
-17.66%
Revenues
11.97b
P
42,657,664,56970,763,645,12368,633,059,69765,185,919,682077,775,981,11373,536,856,40256,679,294,49789,649,488,53486,168,230,46393,564,001,99261,193,499,16288,345,465,761116,980,418,12531,635,113,18693,736,000,00057,948,000,00026,500,000,000-8,219,000,00011,970,000,000
Net income
1.70b
+70.44%
989,719,1951,287,081,0101,712,348,8951,878,036,68801,093,090,5682,208,606,0002,313,377,2203,550,362,7932,219,547,1853,449,134,6033,820,797,3452,370,141,8873,229,860,6703,819,409,197783,000,0002,118,000,0002,214,000,000998,000,0001,701,000,000
CFO
832m
-22.82%
003,910,581,6891,899,851,2641,417,546,531174,635,7713,006,544,0172,698,422,556720,738,1912,183,269,2972,845,224,7543,752,648,1872,715,607,6492,189,277,9433,126,586,133-735,000,0001,966,000,000278,000,0001,078,000,000832,000,000
Dividend
Sep 05, 20246.84 GBP/sh
Earnings
May 23, 2025

Profile

Prudential plc, through its subsidiaries, provides life and health insurance, and retirement and asset management solutions to individuals in Asia, and Africa. It offers health and protection, as well as savings products, such as participating, linked, and other traditional products. The company also provides insurance against common critical illnesses, including cancer, stroke, and heart attack; and tropical disease protection, such as dengue, malaria, and measles. It manages assets across equity, fixed income, multi asset, quantitative, and alternative strategies on behalf of institutional and individual investors. Prudential plc provides its products and services through agency sales force, banks, and brokers. The company was founded in 1848 and is headquartered in London, the United Kingdom.
URL
https://www.prudentialplc.com/
IPO date
Dec 29, 1978
Employees
14,671
Domiciled in
GB
Incorporated in
GB

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11,970,000
-245.64%
(8,219,000)
-131.02%
Cost of revenue
3,100,000
Unusual Expense (Income)
NOPBT
11,970,000
(11,319,000)
NOPBT Margin
100.00%
137.72%
Operating Taxes
385,000
454,000
Tax Rate
3.22%
NOPAT
11,585,000
(11,773,000)
Net income
1,701,000
70.44%
998,000
-54.92%
Dividends
(533,000)
(474,000)
Dividend yield
3.46%
3.07%
Proceeds from repurchase of equity
4,000
(4,000)
BB yield
-0.03%
0.03%
Debt
Debt current
699,000
501,000
Long-term debt
4,409,000
4,874,000
Deferred revenue
Other long-term liabilities
(5,425,000)
(3,946,000)
Net debt
(148,094,000)
(137,291,000)
Cash flow
Cash from operating activities
832,000
1,078,000
CAPEX
(44,000)
(34,000)
Cash from investing activities
(360,000)
(39,000)
Cash from financing activities
(1,210,000)
(2,520,000)
FCF
26,971,000
(11,674,000)
Balance
Cash
1,590,000
5,514,000
Long term investments
151,612,000
137,152,000
Excess cash
152,603,500
143,076,950
Stockholders' equity
12,271,000
12,121,000
Invested Capital
161,244,000
147,741,000
ROIC
7.50%
ROCE
6.85%
EV
Common stock shares outstanding
1,373,500
1,368,000
Price
11.23
-0.44%
11.28
-34.50%
Market cap
15,417,538
-0.04%
15,424,200
-31.81%
EV
(132,516,462)
(121,699,800)
EBITDA
11,970,000
(10,349,000)
EV/EBITDA
11.76
Interest
172,000
200,000
Interest/NOPBT
1.44%